USPTO serial 79001353
MELIORAX
Reviewed by CopyMark Law Group
Reg. 3006030Status 404
- Filing date
- Status date
- Registration date
- Oct 11, 2005
- Examiner
- WELLS, CHRISTOPHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MELIORAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-depressive pharmaceutical preparations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 28, 2013 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 19, 2013 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 31, 2012 | C71T | CANCELLED SECTION 71 | — |
| Dec 4, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 31, 2007 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 10, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 11, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2006 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 19, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 11, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 29, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 11, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 1, 2005 | ALIE | ASSIGNED TO LIE | — |
| Mar 31, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 30, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 21, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2005 | PAPER RECEIVED | — | |
| Oct 7, 2004 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 8, 2004 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |